We have examined the effects of -thyroxine (T % ) on the activation of signal transducer and activator of transcription 3 (STAT3) and on the STAT3-dependent induction of c-Fos expression by epidermal growth factor (EGF). T % , at a physiological concentration of 100 nM, caused tyrosine phosphorylation and nuclear translocation (i.e. activation) of STAT3 in HeLa cells in as little as 10-20 min. Activation by T % of STAT3 was maximal at 30 min (15p4-fold enhancement ; meanpS.E.M.) in 18 experiments. This effect was reproduced by T % -agarose (100 nM) and blocked by CGP 41251, genistein, PD 98059 and geldanamycin, inhibitors of protein kinase C (PKC), protein tyrosine kinase (PTK), mitogen-activated protein kinase (MAPK) kinase and Raf-1 respectively. Tyrosine-phosphorylated MAPK also appeared in nuclear fractions within 10 min of treatment with T % .
INTRODUCTION
The 92 kDa signal transducer and activator of transcription (STAT3) is involved in the transduction of cytokine and growth factor signals, such as those of epidermal growth factor (EGF) [1] , granulocyte colony-stimulating factor [2] , erythropoietin and interleukin 3 [3] and interleukin 6 [1, 4] . When stimulated by EGF, STAT3 is tyrosine-phosphorylated at residue 705 and translocates to the nucleus, either as a homodimer or as a heterodimer with the 91 kDa STAT1α, where it binds to selected EGF-responsive DNA sequences [5] . STAT3 and STAT1α both contain a C-terminal serine residue (residue 727) that is subject to phosphorylation by the mitogen-activated protein kinase (MAPK) pathway [6, 7] , as well as by other serine kinases [6] [7] [8] .
We have previously described the potentiation of antiviral and immunomodulatory effects of interferon γ (IFN-γ) by physiological concentrations of thyroid hormone in HeLa cells [9] [10] [11] [12] , which are known to contain no functional nuclear thyroid hormone receptor (TR) [13] . The several actions of IFN-γ are known to depend on the cytokine's stimulation of the tyrosine phosphorylation cascade involving the IFN-γ receptor, Janus kinases 1 and 2, and tyrosine phosphorylation of the 91 kDa STAT1α [5] . We have established that physiological concentrations of thyroid hormone non-genomically cause the tyrosine phosphorylation and nuclear translocation of STAT1α [14] . We therefore postulated that thyroid hormone also causes the tyrosine phosphorylation and nuclear accumulation of STAT3, thus potentiating the cellular actions of EGF. The studies reported here support an action of thyroid hormone on the activation of STAT3, leading to potentiation by thyroid hormone Abbreviations used : EGF, epidermal growth factor ; IFN-γ, interferon γ ; MAPK, mitogen-activated protein kinase ; MEK, MAPK kinase ; PKC, protein kinase C ; PTK, protein tyrosine kinase ; STAT1α and STAT3, signal transducers and activators of transcription 1α and 3 ; T 4 , L-thyroxine ; TR, thyroid hormone receptor. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed at the Department of Medicine, Albany Medical College (e-mail pjdavis!albany.net).
In the nuclear fraction of T % -treated cells, MAPK immunoprecipitate also contained STAT3. The actions of T % were similar in HeLa and CV-1 cells, which lack thyroid hormone receptor (TR), and in TR-replete skin fibroblasts (BG-9). T % also potentiated the EGF-induced nuclear translocation of activated STAT1α and STAT3 and enhanced the EGF-stimulated expression of c-Fos. Hormone potentiation of EGF-induced signal transduction and c-Fos expression was inhibited by CGP 41251, geldanamycin and PD 98059. Therefore the non-genomically induced activation by T % of STAT3, and the potentiation of EGF by T % , require activities of PKC, PTK and an intact MAPK pathway.
modified by Weinstein et al. [17] . The concentrations of total and free endogenous T % in this 0.25 % hormone-depleted serumsupplemented medium were 23 pM and 10 fM respectively ; the free T $ concentration was below the limits of measurement [11] . After 48 h, cells were incubated with hormone 3,5,3h-triiodothyronine, EGF and\or other reagents for various periods as indicated. Stock solutions containing 100 µM T % were prepared in 0.04 M KOH\4 % (v\v) propylene glycol, and dilutions were made to a final concentration of 100 nM total T % and 100 pM free T % in culture medium. This physiological concentration of T % was used in all experiments. T % -agarose was provided as a suspension in 0.5 M NaCl, containing approx. 6 mM T % , and was diluted in culture medium to a final T % concentration of 100 nM. DMSO (0.1 %, v\v) was the solvent for all inhibitors. This concentration of DMSO caused minimal activation of signaltransducing proteins.
Cell harvesting and preparation of nuclear extracts were then performed as follows : cultures were washed twice with ice-cold PBS, then lysed in hypotonic buffer [20 mM Hepes (pH 7.9)\ 10 mM KCl\0.1 mM Na $ VO % \1 mM EDTA\10 % (v\v) glycerol\1 mM PMSF\3 µg\ml aprotinin\1 mg\ml pepstatin\ 20 mM NaF\1 mM dithiothreitol] with 0.2 % (v\v) Nonidet P40 on ice for 10 min. After centrifugation at 4 mC and 14 000 g for 1 min, supernatants were collected as cytoplasmic extracts. Nuclear extracts were prepared with the method of Wen et al. [6] by resuspension of the crude nuclei in high-salt buffer [hypotonic buffer containing 20 % (v\v) glycerol and 420 mM NaCl] at 4 mC for 30 min. The supernatants were collected after centrifugation at 4 mC and 14 000 g for 10 min.
Immunoprecipitation and immunoblotting
After normalization of protein content, immunoprecipitation was performed with polyclonal anti-phosphotyrosine (Transduction Laboratories, Lexington, KY, U.S.A.). After incubation overnight at 4 mC with rocking, Protein A-agarose was added and samples remained for 1 h at 4 mC with rocking. After two washes with hypotonic buffer containing 0.2 % (v\v) Nonidet P40, immunoprecipitates were eluted with 2isample buffer and proteins separated by discontinuous SDS\PAGE. In selected studies, immunoprecipitation was performed with monoclonal anti-MAPK (ERK2 ; Transduction) and Protein A-agarose. 
RESULTS

Promotion by T 4 of phosphorylation and nuclear uptake of STAT3
HeLa cells were treated with 100 nM T % for up to 180 min. The resulting total and free T % concentrations in the treatment medium were 100 nM and 100 pM respectively. phorylated STAT3 (activated STAT3) during exposure to T % for 10-180 min. In this representative blot, the enhancement of STAT3 was 15-fold in 30 min, as compared with untreated control cells. In two experiments the fold increases in activated STAT3 (meanspS.E.M.) after 30, 60, 120 and 180 min, as compared with untreated control samples, were 11p4, 3p0.8, 2p0.7 and 3p0.1 respectively. In experiments with HeLa, BG-9 and CV-1 cells, the fold increases in STAT3 activation with T % treatment for 30 min, as compared with untreated control cells, were 15p4 (n l 18 experiments), 23p6 (n l 8) and 5p2 (n l 3) respectively. A similar pattern of STAT1α activation in HeLa cells is seen in Figure 1 (B), with 17-fold enhancement occurring at 30 min. In five experiments in HeLa cells there was 8p3-fold, 5p1-fold, 7p5-fold and 6p4-fold stimulation of STAT1α activation by T % after 30, 60, 120 and 180 min respectively.
In Figure 1 (C) the effect of T % -agarose on STAT3 activation in CV-1 cells is shown. T % added to cells for 30 min stimulated the activation of STAT3 (2.7-fold ; Figure 1C , lane 3) in this study. T % -agarose containing 100 nM T % , added for 30 min, also caused activation of STAT3 (2.5-fold ; Figure 1C , lane 4) and a preparation of T % -agarose washed three times with PBS and reconstituted at the same T % -agarose concentration also activated STAT3 (2.7-fold ; Figure 1C , lane 5). Protein A-agarose, added to the cell medium at the same agarose concentration as with T % -agarose, had no effect on tyrosine phosphorylation and . These results indicate that T % exerts its effect through contact with a cell-surface site and that transport of T % into the cytoplasm is not necessary for hormone action. Similar results have been obtained in studies of the activation of STAT1α by T % -agarose [14] . EGF was not present in these experiments.
Samples of TR-replete human skin fibroblasts (BG-9 cells) were treated for 70 min with CGP 41251 (1-100 nM), an inhibitor of the conventional, Ca# + -requiring PKC isoforms PKC-α, PKC-βI, PKC-βII and PKC-γ [18] ; T % was added during the last 30 min. In the experiment shown in Figure 2(A) , thyroid hormone caused a 26-fold activation of STAT3 in BG-9 cells in 30 min, and this activation was inhibited 14 %, 81% and 80 % by 1, 50 and 100 nM CGP 41251 respectively. Genistein, a PTK inhibitor, also inhibited the effect of thyroid hormone. In the BG-9 cell study shown in Figure 2( 
Association of STAT3 and MAPK in nuclear fractions of T 4 -treated cells
We have previously shown that treatment of HeLa cells with 100 nM T % leads to the complexing of activated MAPK and STAT1α in MAPK immunoprecipitates [20] . To determine whether MAPK also complexed with STAT3 on exposure of cells to T % , we treated HeLa cells with T % for 10-120 min. Nuclear samples were then immunoprecipitated with antibody against MAPK ; the immunoprecipitated proteins were separated by PAGE and immunoblotted with anti-phosphotyrosine, anti-STAT3 or anti-STAT1α. In Figure 3 (A) an increase in tyrosinephosphorylated MAPK induced by T % is seen in a representative immunoblot, with a maximal effect at 10 and 30 min (5-fold and 4.5-fold increases respectively). Immunoblotting of immunoprecipitated samples with anti-STAT3 ( Figure 3B ) or anti-STAT1α ( Figure 3C ) revealed that these signal transduction proteins co-precipitated with MAPK in the nuclear fractions during the same period. In the representative experiment shown in Figure 3 , 2-fold and 5-fold enhancements respectively of STAT3 and STAT1α complexing with MAPK occurred in cells treated with T % for 30 min. Because of the association of MAPK with STAT1α and STAT3, the contribution of the MAPK pathway to the activation and nuclear translocation of STAT3 in the absence of EGF was examined. PD 98059 is an inhibitor of MAPK kinase (MEK), with an IC &! of 2 µM and a maximal effect at 10-100 µM [21] . HeLa cells were treated with T % , with or without this inhibitor, for 30 min. In the experiment shown in Figure 4 (A), T % -induced tyrosine phosphorylation and nuclear translocation of STAT3 were inhibited 48 % and 88 % by 0.3 and 30 µM PD 98059 respectively. Parallel experiments were conducted with geldanamycin, a benzoquinone ansamycin that at 1-2 µM binds heat shock protein 90, thus destabilizing Raf-1 and inhibiting the MAPK cascade [22] . BG-9 cells were treated with geldanamycin for 16 h and T % for the last 30 min. In the experiment shown in Figure 4 (B), T % -induced STAT3 activation (5.2-fold) was inhibited 84 % and 98 % by 0.5 and 10 µM geldanamycin respectively. These studies were performed in the absence of EGF.
Potentiation by T 4 of transduction of EGF signal
The interaction between EGF and T % was then investigated. HeLa cells were treated with 10-100 ng\ml EGF, with or without T % . In Figure 5 nuclear accumulations of activated STAT3, STAT1α and MAPK are seen with 100 nM T % ( Figure 5 , lanes 2 : 6-fold, 3-fold and 14-fold increases over control cells respectively, in representative blots), with 10 ng\ml EGF (lanes 3 : 2-fold, 3-fold and 3-fold increases respectively) and with 100 ng\ml EGF (lanes 4 : 6-fold, 4-fold and 11-fold increases respectively). T % potentiated the nuclear translocation of the three tyrosinephosphorylated signal transduction proteins in the presence of a submaximal concentration of EGF (10 ng\ml) (comparing lanes 3 and 5 : 5-fold, 1.3-fold and 5-fold increases over the effect of EGF alone on STAT3, STAT1α and MAPK respectively). T % potentiated the effect of 100 ng\ml EGF on STAT3 activation (2-fold increase ; Figure 5 , lane 4 compared with lane 6), but not on STAT1α activation. There was a diminution in nuclear activated MAPK in cells treated with T % and EGF (100 rather than 10 ng\ml), suggesting the early stimulation of MAPK activation by the higher EGF concentration, followed by enhanced phosphatase activity and\or the return of MAPK to the cytoplasm.
The effect of MAPK pathway inhibition on STAT3 activation in response to 10 ng\ml EGF, with or without T % , was also examined. Figure 6 (A) demonstrates an increased nuclear accumulation of tyrosine-phosphorylated STAT3 in BG-9 cells exposed to either T % or 10 ng\ml EGF (lanes 2 and 3 respectively) and 5-fold potentiation by T % of the EGF effect (lane 6) in a representative blot. Geldanamycin (0.5 and 10 µM) in fact enhanced the effect of EGF alone on STAT3 activation (2-fold and 3-fold increases respectively ; Figure 6A , lanes 4 and 5), but partly inhibited the T % potentiation of EGF action on STAT3 in a dose-dependent manner (51 % and 71 % inhibitions respectively ; lanes 7 and 8 compared with lane 6).
HeLa cells were treated with PD 98059 in the presence of T % , EGF or both. In the experiment shown in Figure 6 
Actions of T 4 and EGF on c-fos expression
With the knowledge that T % potentiated signal transduction pathways involved in the actions of EGF, we investigated whether thyroid hormone potentiated the action of EGF on c-fos gene expression. HeLa cells were treated with 100 ng\ml EGF, with or without 100 nM T % , for 1 h. Nuclear fractions were prepared and immunoblotted for the presence of c-Fos protein. EGF increased the expression of c-Fos 23p12-fold as compared with control cells in the three experiments shown (lanes 3), and the effect was potentiated by the addition of T % to the EGF incubation ( Figure  7, lanes 4 ; 1.6p0.2-fold enhancement) .
To study the role of the MAPK pathway and PKC activity in T % potentiation of EGF-induced c-Fos expression, HeLa cells were pretreated with either geldanamycin, PD 98059 or CGP 41251 for 16 h, after which EGF (100 ng\ml) and\or T % were added for 1 h. Geldanamycin, at a low concentration of 0.5 µM, partly blocked the effect of EGF ( Figure 7A In two experiments T 4 activated STAT3, STAT1α and MAPK 6-fold, 3-fold and 11-fold respectively. EGF (10 ng/ml) activated STAT3, STAT1α and MAPK 2-fold, 3-fold and 3-fold respectively ; at 100 ng/ml, EGF stimulated these effects 21-fold, 4-fold and 10-fold respectively. The growth factor effect on STAT3, STAT1α and MAPK activation in two experiments was enhanced by T 4 7-fold, 4-fold and 3-fold respectively with 10 ng/ml EGF, and 2-fold (STAT3) and 1.5-fold (STAT1α) with 100 ng/ml EGF. Activation of MAPK decreased 93 % when T 4 was added to 100 ng/ml EGF. concentration ( Figure 7B , 39 % inhibition, comparing lanes 4 and 6), whereas the action of EGF alone was not appreciably affected (lanes 3 and 5). In a study with CGP 41251 shown in Figure 7 (C), the T % potentiation of EGF action was inhibited Thyroid hormone, epidermal growth factor and STAT3 77 % by 2.5 nM CGP 41251 (comparing lanes 4 and 6), whereas cells treated with EGF alone were inhibited 60 % in the experiment shown (comparing lanes 3 and 5). Additional studies were performed with 10 ng\ml EGF, and showed 8-fold enhancement of c-Fos expression by EGF, 2-fold potentiation of the EGF effect by T % in three experiments, and, as with the higher EGF concentration, greater inhibition of c-Fos expression in the presence of T % than in its absence. These findings support our premise that T % potentiation of the EGF effect is primarily dependent on the activity of the MAPK pathway, and that the effect of EGF, alone, does not depend to the same extent on this pathway.
DISCUSSION
We have shown that T % in physiological concentrations stimulates the tyrosine phosphorylation and nuclear translocation of STAT1α and enhances the activation of STAT1α induced by IFN-γ [14] . This thyroid hormone effect is blocked by inhibitors of PTK and PKC [14] ; physiological concentrations of T % cause a greater response than physiological concentrations of T $ [14] . In the present studies we have extended the role of T % in signal transduction to include the phosphorylation of STAT3. STAT3 also requires tyrosine phosphorylation (at residue 705, as compared with residue 701 for STAT1α) for activation and nuclear translocation and is susceptible to phosphorylation at Figure) and a 23p18 % inhibition of the effect of EGF alone (little inhibition in this Figure) . (C) The potentiation by T 4 of EGF-induced c-Fos (lower band) was inhibited 85p3 % by 2.5 nM CGP 41251 in four experiments (77 % in this Figure) , whereas the effect of EGF alone was inhibited 59p11 % in four experiments (60 % in this Figure) .
Serine-727. T % or T % -agarose in the absence of EGF promoted the tyrosine phosphorylation and nuclear uptake of STAT3 as well as that of STAT1α. The effect of thyroid hormone on STAT3 in the absence of EGF was inhibited by agents that block activities of PKC and PTK. A mechanism by which T % -driven tyrosine phosphorylation of STAT3 can be affected by PKC inhibition is discussed below. In the presence of EGF, T % potentiated the phosphorylation and nuclear transport of STAT3 induced by EGF. Similar findings were obtained in HeLa and CV-1 cells, which lack functional TR [15] , and in BG-9 cells, which are TRreplete, indicating the non-genomic nature of this thyroid hormone action.
We also found that T % , in the absence of EGF, promoted the nuclear translocation of tyrosine-phosphorylated MAPK. EGF alone also increased the phosphorylation and nuclear uptake of MAPK ; the effect of EGF on MAPK was enhanced by T % . STAT3 has been shown by others to undergo Serine-727 phosphorylation by the MAPK pathway [23] , as well as by a mechanism independent of that pathway [7] . This serine phosphorylation has been regarded as essential for maximal transcriptional activity of STAT3 [6] . We have previously shown that 100 nM T % causes the tyrosine phosphorylation and nuclear translocation of MAPK [20] and STAT1α [14] . We believe that
